Glucosidase, Beta, Acid 3 (Cytosolic) (GBA3) (N-Term) Peptid
Kurzübersicht für Glucosidase, Beta, Acid 3 (Cytosolic) (GBA3) (N-Term) Peptid (ABIN8101565)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- N-Term
-
Verwendungszweck
- GBA3 Peptide - N-terminal region
-
Sequenz
- LTHYRFSLSW SRLLPDGTTG FINQKGIDYY NKIIDDLLKN GVTPIVTLYH
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-GBA3 Antibody(ARP57505_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- GBA3 (Glucosidase, Beta, Acid 3 (Cytosolic) (GBA3))
-
Hintergrund
-
Background Information: GBA3, or cytosolic beta-glucosidase (EC 3.2.1.21), is a predominantly liver enzyme that efficiently hydrolyzes beta-D-glucoside and beta-D-galactoside, but not any known physiologic beta-glycoside, suggesting that it may be involved in detoxification of plant glycosides (de Graaf et al., 2001 [PubMed 11389701]). GBA3 also has significant neutral glycosylceramidase activity (EC 3.2.1.62), suggesting that it may be involved in a nonlysosomal catabolic pathway of glucosylceramide metabolism (Hayashi et al., 2007 [PubMed 17595169]).
Alternative Symbols: CBGL1, GLUC, KLrP, MGC104276, MGC126878
-
Molekulargewicht
- 54kDa
-
Gen-ID
- 57733
-
NCBI Accession
- NP_066024
-
UniProt
- Q9H227
Target
-
